Literature DB >> 32712257

Quantitative Dynamic Contrast-Enhanced MRI Identifies Radiation-Induced Vascular Damage in Patients With Advanced Osteoradionecrosis: Results of a Prospective Study.

Abdallah S R Mohamed1, Renjie He1, Yao Ding1, Jihong Wang1, Joly Fahim1, Baher Elgohari1, Hesham Elhalawani1, Andrew D Kim2, Hoda Ahmed2, Jose A Garcia2, Jason M Johnson3, R Jason Stafford4, James A Bankson4, Mark S Chambers2, Vlad C Sandulache5, Clifton D Fuller1, Stephen Y Lai6.   

Abstract

PURPOSE: We aim to characterize the quantitative dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) parameters associated with advanced mandibular osteoradionecrosis (ORN) compared with the contralateral normal mandible. METHODS AND MATERIALS: Patients with a diagnosis of advanced ORN after curative-intent radiation treatment of head and neck cancer were prospectively enrolled after institutional review board approval and study-specific informed consent were obtained. Quantitative maps generated with the Tofts and extended Tofts pharmacokinetic models were used for analysis. Manual segmentation of advanced ORN 3-dimensional volume was done using anatomic sequences to create ORN volumes of interest (VOIs). Subsequently, normal mandibular VOIs were segmented on the contralateral healthy mandible of similar volume and anatomic location to create control VOIs. Finally, anatomic sequences were coregistered to DCE sequences, and contours were propagated to the respective parameter maps.
RESULTS: Thirty patients were included. The median time to ORN diagnosis after completion of IMRT was 38 months (range, 6-184 months), whereas median time to ORN progression to advanced grade after initial diagnosis was 5.6 months (range, 0-128 months). There were statistically significant higher Ktrans and Ve in ORN-VOIs compared with controls (0.23 vs 0.07 min-1, and 0.34 vs 0.15; P < .0001 for both). The average relative increase of Ktrans in ORN-VOIs was 3.2-fold higher than healthy mandibular control VOIs. Moreover, the corresponding rise of Ve in ORN-VOIs was 2.7-fold higher than in the controls. Using combined Ktrans and Ve parameters, 27 patients (90%) had at least a 200% increase of either of the studied parameters in the ORN-VOIs compared with their healthy mandible VOIs.
CONCLUSIONS: Our results confirm that there is a quantitatively significant higher degree of leakiness in the mandibular vasculature as measured using DCE-MRI parameters of areas with advanced ORN versus healthy mandible.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32712257      PMCID: PMC7680450          DOI: 10.1016/j.ijrobp.2020.07.029

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

Review 1.  Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.

Authors:  Travis C Salzillo; Nicolette Taku; Kareem A Wahid; Brigid A McDonald; Jarey Wang; Lisanne V van Dijk; Jillian M Rigert; Abdallah S R Mohamed; Jihong Wang; Stephen Y Lai; Clifton D Fuller
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

2.  Three-Dimensional Evaluation of Isodose Radiation Volumes in Cases of Severe Mandibular Osteoradionecrosis for the Prediction of Recurrence after Segmental Resection.

Authors:  Haye H Glas; Joep Kraeima; Silke Tribius; Frank K J Leusink; Carsten Rendenbach; Max Heiland; Carmen Stromberger; Ashkan Rashad; Clifton D Fuller; Abdallah S R Mohamed; Stephen Y Lai; Max J H Witjes
Journal:  J Pers Med       Date:  2022-05-20

Review 3.  MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers.

Authors:  Samuel L Mulder; Jolien Heukelom; Brigid A McDonald; Lisanne Van Dijk; Kareem A Wahid; Keith Sanders; Travis C Salzillo; Mehdi Hemmati; Andrew Schaefer; Clifton D Fuller
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575

4.  Three-dimensional (3D) anatomic location, extension, and timing of severe osteoradionecrosis of the mandible.

Authors:  Lucas G Sapienza; Justin J Thomas; Weiyuan Mai; Alexander N Hanania; Sandeep Hunjan; Vlad C Sandulache; Albert C Chen
Journal:  Rep Pract Oncol Radiother       Date:  2022-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.